What top creators are saying about Xeris Biopharma Holdings, Inc.(XERS)

Biopharmaceutical company developing and commercializing therapies for endocrine and other diseases.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 2 scored insights about Xeris Biopharma Holdings, Inc..

Bullish
avg +0.15
1 bullish1 neutral0 bearish

Top creators covering Xeris Biopharma Holdings, Inc. (XERS)

The 1 sources with the most insights about Xeris Biopharma Holdings, Inc. on Kazuha.

Latest insights about Xeris Biopharma Holdings, Inc. (XERS)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral

Mentioned as a company with revenue and a pipeline, including a drug associated with Cushing’s syndrome. Trading around earnings was floated, but no clear recommendation or outlook was given.

Bullish

The speaker described the company as having revenue and a pipeline and called it not such a bad thing, but gave no specific recommendation.

Discussed alongside Xeris Biopharma Holdings, Inc. (XERS)

Other assets that creators frequently mention in the same content as Xeris Biopharma Holdings, Inc..

Frequently asked

Which podcasters and creators cover Xeris Biopharma Holdings, Inc. (XERS) the most?

The most active sources covering Xeris Biopharma Holdings, Inc. (XERS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Xeris Biopharma Holdings, Inc. (XERS) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Xeris Biopharma Holdings, Inc. (XERS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Xeris Biopharma Holdings, Inc. (XERS)?

Creators covering Xeris Biopharma Holdings, Inc. (XERS) most frequently also discuss OSUR, ZURA, NAUT, PLTR, HUMA. See the "Discussed alongside" section above for full asset pages.